Publications

  1. Hlady RA, Zhou D, Puszyk W, Roberts LR, Liu C, Robertson KD. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer. Epigenetics 2017 Jan 06; 0 [Epub ahead of print]
    View PubMed
  2. Zhou D, Hlady RA, Schafer MJ, White TA, Liu C, Choi JH, Miller JD, Roberts LR, LeBrasseur NK, Robertson KD. High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver. Epigenetics 2017 Jan 02; 12 (1):55-69 Epub 2016 Nov 18
    View PubMed
  3. Piao Y, Lee SK, Lee EJ, Robertson KD, Shi H, Ryu KH, Choi JH. CAME: identification of chromatin accessibility from nucleosome occupancy and methylome sequencing. Bioinformatics 2016 Dec 29 [Epub ahead of print]
    View PubMed
  4. Tiedemann RL, Hlady RA, Hanavan PD, Lake DF, Tibes R, Lee JH, Choi JH, Ho TH, Robertson KD. Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma. Oncotarget 2016 Jan 12; 7 (2):1927-46
    View PubMed
  5. Yun S, Vincelette ND, Abraham I, Robertson KD, Fernandez-Zapico ME, Patnaik MM. Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials. Clin Epigenetics 2016; 8:68 Epub 2016 June 14
    View PubMed
  6. Zhang W, Li Y, Kulik M, Tiedemann RL, Robertson KD, Dalton S, Zhao S. Nucleosome positioning changes during human embryonic stem cell differentiation Epigenetics 2016; 11 (6):426-37
  7. Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N, Koomen J, Chen J, Lane WS, Seto E. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol. 2011 Dec; 31(23):4720-34. Epub 2011 Sep 26.
    View PubMed
  8. Liu F, Liu Q, Yang D, Bollag WB, Robertson K, Wu P, Liu K. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3. Cancer Res. 2011 Nov 1; 71(21):6807-16. Epub 2011 Sep 12.
    View PubMed
  9. Liu H, Dong H, Robertson K, Liu C. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. Am J Pathol. 2011 Feb; 178(2):652-61.
    View PubMed
  10. Ha K, Lee GE, Palii SS, Brown KD, Takeda Y, Liu K, Bhalla KN, Robertson KD. Rapid and transient recruitment of DNMT1 to DNA double strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery. Hum Mol Genet. 2010; 20(1):126-140.
  11. Qiu J, Ai L, Ramachandran C, Yao B, Gopalakrishnan S, Fields CR, Delmas AL, Dyer LM, Melnick SJ, Yachnis A, Schwartz PH, Fine HA, Brown KD, Robertson KD. Invasion suppressor CST6 (cystatin E/M): High-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Lab Invest. 2008; 88(9):910-925.
  12. Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD, Brown KD. Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer. 2008; 48(1):83-97.
  13. Ai L, Kim T-Y, Kim W-J, Fields CR, Massoll NA, Robertson KD, Brown KD. Epigenetic silencing of the metastasis suppressor cystatin M occurs during breast cancer progression. Cancer Res. 2006; 66(16):7899-7909.
  14. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. The Epstein-Barr virus (EBV) latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol. 1998; 72(9):7075-83.